![Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial - The Lancet Psychiatry Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/54131111-0636-4405-8112-24d76b464cfc/gr1_lrg.gif)
Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial - The Lancet Psychiatry
![Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in ... Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in ...](https://www.jaacap.org/cms/attachment/9dd41fba-f360-4a18-9cf2-6f2075fd3f43/gr1.jpg)
Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in ...
![These highlights do not include all the information needed to use QUETIAPINE TABLETS safely and effectively. See full prescribing information for QUETIAPINE TABLETS.QUETIAPINE tablets, for oral use Initial U.S. Approval: 1997 These highlights do not include all the information needed to use QUETIAPINE TABLETS safely and effectively. See full prescribing information for QUETIAPINE TABLETS.QUETIAPINE tablets, for oral use Initial U.S. Approval: 1997](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-5.jpg&id=653166)
These highlights do not include all the information needed to use QUETIAPINE TABLETS safely and effectively. See full prescribing information for QUETIAPINE TABLETS.QUETIAPINE tablets, for oral use Initial U.S. Approval: 1997
![These highlights do not include all the information needed to use QUETIAPINE TABLETS safely and effectively. See full prescribing information for QUETIAPINE TABLETS.QUETIAPINE tablets, for oral use Initial U.S. Approval: 1997 These highlights do not include all the information needed to use QUETIAPINE TABLETS safely and effectively. See full prescribing information for QUETIAPINE TABLETS.QUETIAPINE tablets, for oral use Initial U.S. Approval: 1997](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-7.jpg&id=653166)
These highlights do not include all the information needed to use QUETIAPINE TABLETS safely and effectively. See full prescribing information for QUETIAPINE TABLETS.QUETIAPINE tablets, for oral use Initial U.S. Approval: 1997
![Pharmaceutics | Free Full-Text | Tablet Splitting in Elderly Patients with Dementia: The Case of Quetiapine Pharmaceutics | Free Full-Text | Tablet Splitting in Elderly Patients with Dementia: The Case of Quetiapine](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-13-01523/article_deploy/html/images/pharmaceutics-13-01523-ag.png?1632447936)
Pharmaceutics | Free Full-Text | Tablet Splitting in Elderly Patients with Dementia: The Case of Quetiapine
PACKAGE LEAFLET: INFORMATION FOR THE USER Quetiapine Teva 50 mg, 150 mg, 200 mg, 300 mg, 400 mg prolonged-release tablets quetia
![capsule brown teva 5503 Images - Olanzapine and Fluoxetine - olanzapine and fluoxetine - NDC 0093-5507-56 capsule brown teva 5503 Images - Olanzapine and Fluoxetine - olanzapine and fluoxetine - NDC 0093-5507-56](https://pillbox.pillsync.com/00093-5505-56_F426FA17.jpg)